Incivek Oral Tablet 375Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

INCIVEK: Oral tablet (375mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_14359.JPG
INCIVEK 375mg Tablet
Vertex Pharmaceuticals Inc
Pill Identification: V 375 
Drug Image file DrugItem_17515.JPG
INCIVEK 375mg Tablet
Vertex Pharmaceuticals Inc
Pill Identification: V 375 

What is this Medicine?

TELAPREVIR (tel A pre vir) is an antiviral medicine. It is used with peginterferon alfa and ribavirin to treat hepatitis C. It will not work for colds, flu, or other viral infections.

In-Depth Information

INCIVEK 375mg Tablet

NDC: 511670100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hepatitis C Infection

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
INCIVEK 375mg Tablet
Drug Image file DrugItem_14359.JPG
Vertex Pharmaceuticals Inc
Pill Identification: V 375 
Shape: oblong
Color: purple

Reported Side Effects for INCIVEK 375mg Tablet

Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Ulcer Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gout Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Drug Reaction With Eosinophilia And Systemic Symptoms (DRESS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Vesicular Rash Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Blistery Rash Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Skin Rash Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Itching Around The Anus Incidence:
6.0%*
Severity: MILD
Onset: EARLY
High Uric Acid Level Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Hemorrhoids Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Low Lymphocytes Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
26.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
36.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
39.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
47.0%*
Severity: MILD
Onset: RAPID
Tired Incidence:
56.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for INCIVEK 375mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and INCIVEK 375mg Tablet(Telaprevir)
Grapefruit juice and Telaprevir(Telaprevir)
Although an interaction is possible, these drugs may be used together. The potential for side effects may be increased if grapefruit juice is used with Telaprevir. Your clinician will closely monitor you for side effects during your therapy.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with INCIVEK

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5